Study Examines Why Merck Vaccine Candidate Might Have Increased Likelihood Of Contracting HIV

Trials of Merck’s experimental HIV vaccine were halted in September 2007 because the drug might have increased the likelihood of contracting the virus rather than preventing it, according to a study published Monday in the Journal of Experimental Medicine,

More: continued here

Filed under: HIV / AIDS on November 7th, 2008